| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9522 |
| Human Intestinal Absorption | HIA+ | 1.0000 |
| Caco-2 Permeability | Caco2+ | 0.8911 |
| P-glycoprotein Substrate | Non-substrate | 0.6991 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.8725 |
| Non-inhibitor | 0.9510 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.7993 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7867 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.8026 |
| CYP450 2D6 Substrate | Non-substrate | 0.8118 |
| CYP450 3A4 Substrate | Non-substrate | 0.6696 |
| CYP450 1A2 Inhibitor | Inhibitor | 0.9317 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9249 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9474 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.6187 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9769 |
| CYP Inhibitory Promiscuity | High CYP Inhibitory Promiscuity | 0.5257 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7918 |
| Non-inhibitor | 0.9208 |
| AMES Toxicity | Non AMES toxic | 0.9291 |
| Carcinogens | Non-carcinogens | 0.6457 |
| Fish Toxicity | High FHMT | 0.7412 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9463 |
| Honey Bee Toxicity | High HBT | 0.8576 |
| Biodegradation | Ready biodegradable | 0.7017 |
| Acute Oral Toxicity | III | 0.8919 |
| Carcinogenicity (Three-class) | Warning | 0.5146 |